ReviewInternational journal of molecular sciences2022

What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?

Razmik Mirzayans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.